The Hidradenitis Suppurativa Genetics Consortium at NYU Langone is a consortium of investigators in academia and industry using human genetic studies to improve the clinical management of hidradenitis suppurativa (HS).

Have you been diagnosed with HS? Learn more about our research and how you can partner with us.

Our Mission

Our mission is to use human genetic studies to improve the clinical management of HS. We use human genetic studies of rare and common variant as a starting point to:

• discover HS disease mechanisms
• identify and prioritize drug targets
• improve the accuracy and utility of an HS diagnosis

We recognize that:

• generating clinically meaningful genetic evidence requires cohorts with tens of thousands of participants from diverse genetic ancestries
• genetic research is hindered by a lack of coordination among stakeholders

To facilitate collaboration, we commit to:

• respectful engagement of all stakeholders in gene discovery and clinical translation
• open sharing of data and widespread dissemination of results

Contact Us

Contact one of our team leads: